Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: SOMATIC TP53 SINGLE NUCLEOTIDE VARIANTS, INDELS AND COPY NUMBER ALTERATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML). (May 2023) - Gurney, M.; Mangaonkar, A.; Lasho, T.; Finke, C.; Al-Kali, A.; Gangat, N.; Shah, M.; Alkhateeb, H.; Tefferi, A.; Komrokji, R.; Viswanatha, D.; Reichard, K.; et al.